Prediction of efficacy of disease-modifying antirheumatic drugs, biologic agents and immunosupprresants for rheumatoid arthritis and collagen disease
Not Applicable
Recruiting
- Conditions
- rheumatoid arthritis, collagen disease
- Registration Number
- JPRN-UMIN000017557
- Lead Sponsor
- Keio University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 720
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who thier physicians consider as not appropriate
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method efficacy at week 14
- Secondary Outcome Measures
Name Time Method